The ongoing Oxford GPS PROTECT study encompasses over 1,500 patients and aims to provide "the highest level of evidence in ...

For ten months, Dickerson combed through investigation reports until she found the evidence: the only fingerprints on the bag and tape belonged to April’s husband. He confessed and he's now in prison ...

India faces a growing crisis in wound treatment, driven by diabetes and an ageing population. A new policy approach could ...

Discover six RNAi biotech companies helping to drive momentum in a field that can precisely target disease at its genetic root.

Market valued at $1.45B in 2024 grows at 10.4% CAGR driven by biocompatible hemostatic solutions in surgical and trauma ...

The AAR held that Dry Citrate Powder used in haemodialysis is not an instrument or apparatus under Chapter 90. It was classified under HSN 29181590 as an organic chemical, attracting 18% ...

"My gym teacher picked a kid up by his unusually large ears. Nobody cared because it was the '80s." View Entire Post › ...

Nature does it again! The natural world has a knack for giving us the blueprints for some useful technologies, and the humble sea urchin is the latest contributor. Scientists have designed a new class ...

Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced positive results from the Phase 3 EV-304 clinical trial (also known as ...

"My kindergarten teacher really had it out for me. I found myself in trouble quite a bit, which is unlike my personality. When you are so young though, you don’t realize an adult might be the one in ...

Qure (QURE) stock plunged 30% as FDA’s Makary warned against approving drugs with morbidity risks. Read more here.

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today reported financial results for the quarter and year ended December ...